Kala Pharmaceuticals, Inc. Gains 88.49%
Tue, Mar 08, 2022 at 05:30 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) shot up at $1.15, representing a gain of 88.5%. On Mon, Mar 07, 2022, KALA:NASDAQ hit a New 2-Week Low of $0.61. The stock got featured on our News Catalysts scanner on Fri, Feb 18, 2022 at 06:36 PM in the 'PRIVATE PLACEMENT' category. From Tue, Feb 22, 2022, the stock recorded 11.11% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- Hycroft Mining Holding Corporation (HYMC:NASDAQ), 203.31%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 88.49%
- Enservco Corporation (ENSV:NYSEMKT), 68%
- Nine Energy Service, Inc. (NINE:NYSE), 57.66%
- Westport Fuel Systems Inc. (WPRT:NASDAQ), 52.63%
- Eco Wave Power Global AB (publ) (WAVE:NASDAQ), 50.9%
- Energy Focus, Inc. (EFOI:NASDAQ), 46.72%
- CYREN Ltd. (CYRN:NASDAQ), 45.59%
- Independence Contract Drilling, Inc. (ICD:NYSE), 40.56%
- PolyMet Mining Corp. (PLM:NYSEMKT), 39.51%